News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Carter Eric G
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2023 |
4
| Carter Eric G (Director) has filed a Form 4 on AEON Biopharma, Inc.
Txns:
| Granted 58,851 options
@ $5.47, valued at
$321.9k
|
|
07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2019 |
4
| Carter Eric G (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns:
| Granted 45,000 options to buy
@ $13.41, valued at
$603.5k
|
|
06/15/2018 |
4
| Carter Eric G (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns:
| Granted 35,000 options to buy
@ $6.25, valued at
$218.8k
|
|
04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/01/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
02/02/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns:
| Unknown transaction of 135,427 shares
@ $0 Disposed/sold 38,740 shares
@ $0 Disposed/sold 55,740 options to buy
@ $0 Disposed/sold 17,860 options to buy
@ $0 Disposed of 34,240 options to buy
@ $8.91, valued at
$305.1k
Disposed of 50,290 options to buy
@ $6.97, valued at
$350.5k
Disposed of 42,240 options to buy
@ $12.44, valued at
$525.5k
|
|
01/20/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/11/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns:
| Granted 16,260 shares
@ $0 |
|
12/01/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/31/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/24/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,772 shares
@ $12.25, valued at
$21.7k
|
|
03/19/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns:
| Granted 11,970 shares
@ $0 Granted 42,240 options to buy
@ $12.44, valued at
$525.5k
|
|
03/01/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns:
| Granted 55,740 options to buy
@ $0 |
|
01/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/05/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC
Txns:
| Exercised 12,698 options to buy
@ $0 |
|
03/25/2009 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
03/12/2009 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
02/19/2009 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
01/21/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|